Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chiu, Yung Tuen ^a   Liu, Ji ^c   Tang, Kaidun ^c   Wong, Yong Chuan ^b   Khanna, Kum Kum ^d   Ling, Ming Tat ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ATM PROTEIN; ATR PROTEIN; HISTONE H2AX; PROTEIN P53;

ARTICLE; ATM GENE; ATR GENE; CANCER CELL; CELL AGING; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL VIABILITY; CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN DEGRADATION; PROTEIN FUNCTION;

EID: 84871322771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051108     Document Type: Article

References (39)

1. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648.
2. Clark JP, Cooper CS, (2009) ETS gene fusions in prostate cancer. Nat Rev Urol 6: 429-439.
3. Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, et al. (2009) SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res 69: 2734-2738.
4. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R,et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 42: 668-675.
5. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069-1083.
6. Bastus NC, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC,et al. Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. Cancer Res 70: 9544-9548.
7. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
8. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
9. Shiloh Y, (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31: 402-410.
10. Zou L, Elledge SJ, (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300: 1542-1548.
11. Costanzo V, Shechter D, Lupardus PJ, Cimprich KA, Gottesman M, et al. (2003) An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 11: 203-213.
12. Khanna KK, Chenevix-Trench G, (2004) ATM and genome maintenance: defining its role in breast cancer susceptibility. J Mammary Gland Biol Neoplasia 9: 247-262.
13. Shiloh Y, (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155-168.
14. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S, (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
15. Fan C, Quan R, Feng X, Gillis A, He L, et al. (2006) ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochim Biophys Acta 1763: 1090-1097.
16. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
17. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677.
18. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, et al. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679.
19. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, et al. (1998) ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 20: 398-400.
20. Iliakis G, Wang Y, Guan J, Wang H, (2003) DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22: 5834-5847.
21. Kristjansdottir K, Rudolph J, (2004) Cdc25 phosphatases and cancer. Chem Biol 11: 1043-1051.
22. Angele S, Falconer A, Edwards SM, Dork T, Bremer M, et al. (2004) ATM polymorphisms as risk factors for prostate cancer development. Br J Cancer 91: 783-787.
23. Meyer A, Wilhelm B, Dork T, Bremer M, Baumann R, et al. (2007) ATM missense variant P1054R predisposes to prostate cancer. Radiother Oncol 83: 283-288.
24. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP, (2002) DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883.
25. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM, (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14: 501-513.
26. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198.
27. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, et al. (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 6: 168-170.
28. Bakkenist CJ, Drissi R, Wu J, Kastan MB, Dome JS, (2004) Disappearance of the telomere dysfunction-induced stress response in fully senescent cells. Cancer Res 64: 3748-3752.
29. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, et al. (2000) Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Oncogene 19: 670-679.
30. Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, et al. (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288: 1425-1429.
31. Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF, (2000) Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep 1: 71-79.
32. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, et al. (2000) Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19: 5406-5417.
33. Isoda M, Kanemori Y, Nakajo N, Uchida S, Yamashita K, et al. (2009) The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest. Mol Biol Cell 20: 2186-2195.
34. Golding SE, Rosenberg E, Neill S, Dent P, Povirk LF, et al. (2007) Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res 67: 1046-1053.
35. Choo CK, Ling MT, Chan KW, Tsao SW, Zheng Z, et al. (1999) Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate 40: 150-158.
36. Luk SU, Yap WN, Chiu YT, Lee DT, Ma S,et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer.
37. Chiu YT, Han HY, Leung SC, Yuen HF, Chau CW, et al. (2009) CDC25A functions as a novel Ar corepressor in prostate cancer cells. J Mol Biol 385: 446-456.
38. Clark J, Merson S, Jhavar S, Flohr P, Edwards S, et al. (2007) Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene 26: 2667-2673.
39. Ling MT, Chiu YT, Lee TK, Leung SC, Fung MK, et al. (2008) Id-1 induces proteasome-dependent degradation of the HBX protein. J Mol Biol 382: 34-43.